6 results
SC TO-C
EX-99.1
eMed, LLC
30 Jan 24
Information about tender offer
10:11am
-term sustainability.
The transaction, which has been unanimously approved by Science 37 Board of Directors, is valued at an equity value
SC14D9C
EX-99.2
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
ability to access unique patients, enroll studies faster, and ensure long-term sustainability.
The transaction values Science 37 shares at $5.75/share … that will streamline our participant experience, and capital to expand our capabilities and ensure long-term sustainability.
Maintaining the Mission
SC14D9C
EX-99.3
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
, and ensure long-term sustainability.
We expect the transaction to close in the first quarter of 2024, subject to customary closing conditions. Upon
SC14D9C
EX-99.4
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
-term sustainability.
We expect the transaction to close in the first quarter of 2024, subject to customary closing conditions. Upon completion
SC14D9C
EX-99.6
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
and ensure sustainability.
9. What are the next steps to complete the merger, and how will it impact my ongoing study(s)?
The merger is expected
8-K
EX-99.1
ca9ql rbsfly5ci
29 Jan 24
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
7:35am
- Prev
- 1
- Next